Researchers report chemical reaction with potential to speed drug development

July 7, 2017, UT Southwestern Medical Center
Catalytic enantioselective oxidation of unactivated terminal and internal alkenes. Credit: Nature (2017). DOI: 10.1038/nature22805

Chemists have long sought to develop new reactions for the direct conversion of simple hydrocarbon building blocks into valuable materials such as pharmaceuticals in a way that dependably creates the same chemical bonds and orientations. UT Southwestern researchers have hit upon a novel way to do that.

The ability to consistently create desirable and avoid undesirable ones could greatly accelerate pharmaceutical production. Many molecules come in two mirror-image configurations, often labeled left-handed and right-handed. Usually, only one of the two is biologically desired, but the issue is more complicated than that, said Dr. Uttam Tambar, Associate Professor of Biochemistry and senior author of a study outlining the reaction published online in Nature.

"Unsaturated hydrocarbons contain only two types of bonds, carbon-hydrogen and carbon-carbon. It is very challenging to selectively transform the starting material , called the feedstock, into a product in which you have selectively transformed one carbon-hydrogen bond into a new bond in every molecule. We are able to do that," Dr. Tambar said.

"We are not only dealing with left- or right-handed configuration; we are also dealing with what position of the molecule is chemically modified," he added.

The selectivity problem challenges chemists, who often encounter it when attempting to directly transform unsaturated hydrocarbons that contain one or more carbon-carbon double bonds, resulting in difficult-to-separate mixtures of compounds that require subsequent chemical steps to subdivide the mixtures into the desired molecules.

"We have developed a method for the direct conversion of a variety of double -containing materials into useful products. A specially designed chiral catalyst is used to oxidize hydrocarbons into multifunctional compounds that are obtained in high purity and are readily converted into an assortment of molecules that will streamline the synthesis of future pharmaceutical drugs," said Dr. Leila Bayeh, a former graduate student and lead author of the study. Dr. Bayeh is now a postdoctoral researcher at the Massachusetts Institute of Technology.

The phrase "chiral catalyst" means that the catalyst that orchestrates the entire reaction has the proper orientation - a left- or right-handed configuration as the situation requires - in order to create the desired transformation, he explained.

The orientation and proper location of all is crucial because the wrong molecule generated from a can be ineffectual or potentially dangerous.

Hence the emphasis on consistency.

Explore further: New chemical reaction could eventually yield new fuels and medications

More information: Liela Bayeh et al. Catalytic allylic oxidation of internal alkenes to a multifunctional chiral building block, Nature (2017). DOI: 10.1038/nature22805

Related Stories

Researchers break down plastic waste

May 26, 2017

What to do proteins and Kevlar have in common? Both feature long chain molecules that are strung together by amide bonds. These strong chemical bonds are also common to many other naturally occurring molecules as well as ...

Recommended for you

Engineers test drug transfer using placenta-on-a-chip

February 16, 2018

Researchers at the University of Pennsylvania's School of Engineering and Applied Science have demonstrated the feasibility of their "organ-on-a-chip" platform in studying how drugs are transported across the human placental ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.